Steven Hite

Steven A. Hite serves as the Chief Executive Officer of Nova Oculus Medical, where Steven leads the development of a novel medical therapy device aimed at reversing the effects of Age-Related Macular Degeneration. Previously, Hite held significant leadership roles, including CEO at Phoenix MedPharma Funders, focusing on pharmaceutical partnerships, and as COO at Alxerion Biotech Corporation, where Steven managed cancer therapeutics initiatives and established a $12M research collaboration with Harvard and MIT. Hite's experience spans various companies, including Centrum Pharma Associates and Thrombotargets Corporation, where Steven contributed to capital raising and innovative medical solutions. Hite holds a BS in Business Management and Marketing from San Jose State University.